comparemela.com

Latest Breaking News On - Daratumumab - Page 4 : comparemela.com

The Evolving Treatment Paradigm for Transplant Ineligible MM

The expert panel discusses how the standard of care for transplant-ineligible NDMM has evolved and reviews recent updates in this space.

Multiple myelomaEvolving treatment paradigmTransplant ineligibleNewly diagnosed multiple myelomaMm treatmentTransplant eligibleRvd liteMash 2023

Treatment of Multiple Myeloma at Early Relapse

A panel of expert hematologic-oncologists offer insights on how they treat patients with multiple myeloma at early relapse.

Multiple myelomaEarly relapseRelapsed refractory mmMm treatmentHigh risk

Optimizing Treatment Management Strategies in AL Amyloidosis with CD-38-Directed mAbs

Faculty share insights into the treatment strategies using CD-38-directed monoclonal antibodies in patients with AL amyloidosis.

Transforming outcomesPrecision medicineTargeted therapiesTreatment management strategiesLight chain amyloidosisAl amyloidosisAffirm alNexicart 1Amyloid depositsCd 38 directed monoclonal antibodiesCardiac involvementMayo cardiac stagingStem cell transplantDuration of therapyUnmet needsManaging al amyloidosis

Treatment Strategies Using Monoclonal Antibodies in AL Amyloidosis

Jeffrey Zonder, MD provides an overview of treatment strategies using monoclonal antibodies for the treatment of AL amyloidosis.

Jeffrey zonderTransforming outcomesPrecision medicineTargeted therapiesStrategies using monoclonal antibodiesLight chain amyloidosisAl amyloidosisAffirm alNexicart 1Amyloid depositsCd 38 directed monoclonal antibodiesCardiac involvementMayo cardiac stagingStem cell transplantDuration of therapyUnmet needs

Additional Analyses Needed to Optimize Treatment Efficacy, Sequencing in MM

This literature review investigated outcomes related to relapsed/refractory multiple myeloma (MM) among patients 65 years and older.

Cochrane collaborationMat haywardRelapsed refractory multiple myeloma

vimarsana © 2020. All Rights Reserved.